BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial ...

HOUSTON, TX and SUNSHINE COAST, QUEENSLAND / ACCESS Newswire / October 6, 2025 / BrYet US, Inc. ("BrYet"), a biotechnology innovator developing a drug with the potential to be a first-in-class ...

Here's How I'm Positioning For The Biggest Market Disruption Of My Lifetime

Investing strategies should focus on index funds, cyclical value stocks, and AI beneficiaries, including infrastructure and ...